Abstract
Background: The optimal surgical approach to tumours of the oesophagus and oesophagogastric junction remains controversial. The principal randomized trial comparing transhiatal (THO) and transthoracic (TTO) oesophagectomy showed no survival difference, but suggested that some subgroups of patients may benefit from the more extended lymphadenectomy typically conducted with TTO.
Methods: This was a cohort study based on two prospectively created databases. Short- and long-term outcomes for patients undergoing THO and TTO were compared. The primary outcome measure was overall survival, with secondary outcomes including time to recurrence and patterns of disease relapse. A Cox proportional hazards model provided hazard ratios (HRs) and 95 per cent confidence intervals (c.i.), with adjustments for age, tumour stage, tumour grade, response to chemotherapy and lymphovascular invasion.
Results: Of 664 included patients (263 THO, 401 TTO), the distributions of age, sex and histological subtype were similar between the groups. In-hospital mortality (1.1 versus 3.2 per cent for THO and TTO respectively; P=0.110) and in-hospital stay (14 versus 17 days respectively; P
Conclusion: There was no difference in survival or tumour recurrence for TTO and THO.
Surgical approach makes little difference to long-term outcomes
Original language | English |
---|---|
Article number | N/A |
Pages (from-to) | 511-517 |
Number of pages | 7 |
Journal | British Journal of Surgery |
Volume | 101 |
Issue number | 5 |
DOIs | |
Publication status | Published - Apr 2014 |
Keywords
- LIMITED TRANSHIATAL RESECTION
- LYMPH-NODE DISSECTION
- ESOPHAGOGASTRIC JUNCTION
- NEOADJUVANT CHEMOTHERAPY
- TRANSTHORACIC RESECTION
- GASTROESOPHAGEAL CANCER
- PREDICTS SURVIVAL
- GASTRIC-CANCER
- CARCINOMA
- NUMBER